Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China · Delayed Price · Currency is CNY 19.27
+0.14 (0.73%)
Jun 1, 2026, 3:00 PM CST
Nanjing Vazyme Biotech Market Cap
Nanjing Vazyme Biotech has a market cap or net worth of 7.66 billion as of June 1, 2026. Its market cap has decreased by -13.97% in one year.
Market Cap
7.66B
Enterprise Value
5.72B
Revenue
1.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
19.27
Market Cap Chart
Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 7.66B, a decrease of -77.55%. That is a compound annual growth rate of -28.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 7.61B | -4.45% |
| Dec 31, 2025 | 7.96B | -9.63% |
| Dec 31, 2024 | 8.81B | -31.21% |
| Dec 29, 2023 | 12.81B | -39.74% |
| Dec 30, 2022 | 21.26B | -49.87% |
| Dec 31, 2021 | 42.40B | 24.19% |
| Nov 15, 2021 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 8.32B |
| Jiangxi Fushine Pharmaceutical | 8.24B |
| Aurisco Pharmaceutical | 8.00B |
| Bio-Thera Solutions | 7.94B |
| GemPharmatech | 7.93B |
| Youcare Pharmaceutical Group | 7.92B |
| Zhejiang Ausun Pharmaceutical | 7.85B |
| Shanghai Medicilon | 7.85B |